The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring provided by the C3i Program are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation.

The eC3i course is an online entrepreneurial education platform aimed at teaching academic innovators methods to assess the commercial value of their biomedical technologies.

Applications for this year’s C3i cohort are due April 14th, 2023. For more information and to apply, visit the NIBIB C3i Program website.